Epogen实际上是一种生物制剂而不是药物,因为它最初是人体中自然产生的一种物质——由肾制造的一种荷尔蒙,用于刺激红血球的再生。
Since then, Amgen has sold more than $25 billion of Epogen, including $2.5 billion last year.
从那个时候开始,安进销售了超过250亿美元的Epogen,包括去年的25亿。
A federal judge has ruled that Mircera, a Roche anemia drug that would compete with Amgen's Epogen and Aranesp, violates an Amgen patent.
一次联邦审判认定Mircera,一个罗氏生产的用于同安进的Epogen和Aranesp竞争的药物,触犯了安进的专利权。
A separate study of dialysis clinics in 2004 found that patients received 21% less Epogen when given subcutaneous injections, the Globe reports.
2004年关于临床透析的一项单独研究发现,患者接受皮下注射给予Epogen时,用量可减少21%,Globe报道。
应用推荐